他汀类药物治疗糖尿病伴代谢综合征的作用机制

被引:7
作者
陈育
黄贵心
机构
[1] 广东医学院附属医院内分泌科
关键词
他汀类; 糖尿病; 代谢综合征X; 综述文献;
D O I
暂无
中图分类号
R587.1 [糖尿病]; R589 [代谢病];
学科分类号
摘要
他汀类药物可用于糖尿病伴有代谢综合征的治疗,其作用机制主要是减轻胰岛素抵抗及胰岛β细胞的损伤,改善高血压、血脂障碍和高血粘度,防治心脑血管疾病、减少心脑动脉事件发生和保护肾功能、减少蛋白尿等。
引用
收藏
页码:215 / 217
页数:3
相关论文
共 22 条
[1]  
ntensive treatment with atorvastatin reduces in-flammation in mononuclear cells andhuman atherosclerotic lesions in onemonth. MARTIN-VENTURA J L,BLANCO-COLIO L M,GOMEZ-HER-NANDEZ A,et al. Stroke . 2005
[2]  
The association be-tween fibrate use,change inhigh-density lipoprotein cholesterol,andthe risk of cardiovascular disease:a retrospective chart review involvingup to 8 years of follow-up. NICHOLS G A,KORO C E,CHAN W,et al. Clinical Therapeutics . 2006
[3]  
The statin studies:from targetinghypercholesterolaemia totargeting thehigh-risk patient. ONG H T. Quarterly Journal of Mathematics . 2005
[4]  
Effect of preexisting statinuse on expression of C-reactive protein,adhesion molecules,inter-leukin-6,and antioxidized low-density lipoprotein antibody in patientswith unstable angina undergoing coronary stenting. DOO Y C,HAN S J,HAN S W,et al. Clinical Cardiology . 2005
[5]  
Fluvastatin amelioratespodocyte injury in proteinuric rats via modulation of excessive Rho sig-naling. SHIBATA S,NAGASE M,FUJITA T. Journal of the American Society of Nephrology . 2006
[6]  
Pravastatinmodulates early diabetic nephropathy in an experimental model of dia-betic renal disease. CASEY R G,JOYCE M,ROCHE-NAGLE G,et al. Journal of Surgical Research . 2005
[7]  
Comparative effects ofpitavastatin and probucol on oxidative stress,Cu/Zn superoxide dismu-tase,PPAR-gamma,and aortic stiffness inhypercholesterolemia. UMEJI K,UMEMOTO S,ITOH S,et al. American Journal of Physiology Heart and Circulatory Physiology . 2006
[8]  
Effectsof rosuvastatin,atorvastatin,simvastatin,and pravastatin on athero-genic dyslipidemia in patients with characteristics of the metabolic syn-drome. DEEDWANIA PC,HUNNINGHAKE D B,BAYS H E,et al. The American Journal of Cardiology . 2005
[9]  
Cerivastatin,a HMG-CoA reductase inhibitor,reduces plasminogen ac-tivator inhibitor-1(PAI-1)expression in endothelial cells by down-reg-ulation of cellular signaling and the inhibition of PAI-1 promoter activity. SWIATKOWSKA M,PAWLOWSKA Z,SZEMRAJ J,et al. Japanese Journal of Pharmacology . 2002
[10]  
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24